Development of the phenylpyrazolo[3,4-d]pyrimidine-based, insulin-like growth factor receptor/Src/AXL-targeting small molecule kinase inhibitor.
Lee HJ, Pham PC, Pei H, Lim B, Hyun SY, Baek B, Kim B, Kim Y, Kim MH, Kang NW, Min HY, Kim DD, Lee J, Lee HY.
Lee HJ, et al. Among authors: kim dd, kim b, kim mh, kim y.
Theranostics. 2021 Jan 1;11(4):1918-1936. doi: 10.7150/thno.48865. eCollection 2021.
Theranostics. 2021.
PMID: 33408789
Free PMC article.